Navigation Links
Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy

Intravascular Ultrasound Demonstrates Utility in Evaluating Drug Efficacy; Dr. H. Bryan Brewer, Jr. Sees Enormous Potential for HDL Therapy

PLEASANTON, CA, Mar 30, 2007 (MARKET WIRE via COMTEX News Network) -- Lipid Sciences, Inc. (NASDAQ: LIPD) Dr. H. Bryan Brewer, Jr., Chief Scientific Director of Lipid Sciences, Inc., concluded from the wide range of presentations at the recent American College of Cardiology (ACC) Meeting in New Orleans that the rationale for HDL being the next, most logical target for the development of treatments for cardiovascular disease continues to exhibit enormous potential. This conclusion is even more compelling in light of the recent, highly publicized failure of the CETP inhibitor, torcetrapib.

This week at the ACC meeting, the latest data on three imaging trials, which included an intravascular ultrasound (IVUS) study, with Pfizer's HDL raising drug, torcetrapib were presented. Torcetrapib is a member of a class of drugs which increase HDL by inhibiting the cholesterol ester transfer protein (CETP). ILLUMINATE, a morbidity and mortality trial comparing the clinical efficacy and safety of torcetrapib/atorvastatin (Lipitor) versus atorvastatin alone was terminated in December 2006 due to an increased number of deaths in those patients taking torcetrapib/atorvastatin. It is important to note that the three imaging trials also failed to show a benefit of torcetrapib/atorvastatin when compared to atorvastatin alone and were consistent with the lack of efficacy that was observed.

Dr. Brewer noted, "The results obtained in the ILLUMINATE trial and the three imaging trials, while unexpected, do not reflect on the potential clinical benefit of raising HDL. Statin drugs have a proven clinical benefit in reducing heart attacks and stroke; however, the reduction in these clinical events is, at best, only approximately one third. A significant number of patien
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. Inspire Announces Presentations at Two European Scientific Conferences
6. Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex (ancrod)
7. IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at 2007 ASCO Annual Meeting
8. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
9. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
10. Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting
11. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007

Post Your Comments:
(Date:11/25/2009)... , LOVELAND, Colo., Nov. 25 /PRNewswire-Fi...a leading provider of advanced diagnostic and sp...nced today agreements with Roche Diagnostics Corpo...filiated consumables for the veterinary market. ...h/20000622/HESKALOGO ) ,, "Heska and Roche shar...
(Date:11/25/2009)... , CHICAGO and STAFA, Switzerland, Nov. 25 /P...ading manufacturer of innovative hearing solutions... for Adults Conference, focusing on the special ne...t together leading experts in aging and audiology ... who work everyday with older people with hearing ...
(Date:11/25/2009)... , COLLEGE PARK, Md., Nov. 25 /PRNewswire-U...y developing a shaving cream-like foam that stops ...e Most Promising Security Idea category of the Glo...ounce today. ,, Selected from more than 100 ent...d their invention at the GSC Security Summit confe...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference 14004 1Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference 14004 2Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 1Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 2Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 3Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 4Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 5HPV Vaccine Study Shows Why Few Women Getting Shots 56961 1HPV Vaccine Study Shows Why Few Women Getting Shots 56961 2
...OF PRUSSIA, Pa., March 31 Successful and seamless...careful forecasting of screened to randomized pati...rategy, and project management guided by real time...iz Moench notes: "This is achievable when clinical...elines." She adds, "We had great team chemistry wi...
...confirms antiplatelet effectiveness of aspirin in ...ch 31 Corgenix Medical Corporation (OTC Bulletin ... Test was used by investigators in The Indian POLY...nse to aspirin and/or statin therapy. , , The TI...pirin, statin and three blood-pressure-lowering dr...
Other Medicine Technology:Major Restless Legs Study Completes Enrollment With Support From MediciGlobal 2Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09 2Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09 3
(Date:11/27/2009)...re-FirstCall/ -- The Gymboree Corporation (Nasdaq:...ll present at the NASDAQ OMX 23rd Investor Program...on, England, on Wednesday, December 2, 2009, at 11...of The Gymboree Corporation,s presentation over th...ck on "Our Company" at the bottom of the page, go ...
(Date:11/27/2009)... Shamir Optical Industry ...ider of innovative products and technology to the ...oard of directors had declared a dividend distribu...roximately NIS 37.62 million based on the November...roximately US$ 0.609 (approximately NIS 2.3 based ...
(Date:11/27/2009)...l, economic burdens, study predicts , , ...people with diabetes in the United States is expec...predicts. , That would bring the total by 2034 ...from 23.7 million today. , , At the same time, t...le, the study also warns, rising from an estimated...
(Date:11/27/2009)...ingual coloring books designed for children ages 2... to educate - inform parents and children alike on...uars to ABC,S and a host of other topics. , ...r 27, 2009 -- Today’s children have enough g...hour of the day, but one of the oldest and simples...
(Date:11/26/2009)...-- With cold and flu season upon us, it,s more imp...ol the spread of infections and avoid illness. ,...lves healthy, but to avoid transmitting illness if...rtified in infection-control), nursing director fo...pital for Special Surgery (HSS) in Manhattan. ,...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
...in Australia have relatively low rates of hospital...essing hospital-based health care, refugee health ...ical Journal of Australia. Deputy Director...inancial years to June 2004. 'We found tha...
...IA -- The science has long been clear that smoking...en could inherit genetic damage from a father who ...rated in mice that smoking can cause changes in th...sue of Cancer Research, a journal of the American ...
...l food market is estimated at around $2.5 trillion...f four percent per annum. A radical shift in food ...ver. In markets, especially in the develop...ation globally is paving the way for introduction ...
...est that detects proteins commonly released by a g...r monitoring the effectiveness of chemotherapy an...at cancer, according to a study published in the J... National Cancer Institute (NCI), two of the Natio...
...rs have found that patients with obstructive sleep... cells (apoptotic cells) from the lining (endothel...loodstream than people who do not have OSA. The fi...ic endothelial cells are correlated with abnormal ...
...ospective study of 700 patients with culture-posit... be significantly higher in HIV-infected patients...ifamycin-based regimen. Furthermore, TB relapse ra...ent. The results appear in the first issue...
Other Medicine News:Health News:Cigarette Smoke Alters DNA in Sperm, Genetic Damage Could Pass to Offspring 2Health News:Nutrient-rich Dairy Beverages an Emerging Market 2Health News:Blood Test may Help Signal Tumor's Remission, Return in Throat Cancer Patients 2Health News:Blood Test may Help Signal Tumor's Remission, Return in Throat Cancer Patients 3Health News:Blood Test may Help Signal Tumor's Remission, Return in Throat Cancer Patients 4Health News:Patients With OSA at Higher Risk for Cardiovascular Disease 2Health News:Patients With OSA at Higher Risk for Cardiovascular Disease 3Health News:Treatment Outcomes of Patients With HIV and Tuberculosis 2
3M Littmann Sound Analysis Software
... with the challenge of,controlling costs while h...y patient data,management is critical. INFINITY ...,access to important clinical information,whe...CK AND GO concept,makes your job easier. You can...
biograph 2
...ation Cardiac is a member of the SOMATOM Sensation... with optimized performance for non invasive cardi...nsation Cardiac we took a defining step towards st...d performance with respect to temporal and spatial...
Medicine Products: